The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).

The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).

From 50 years of age, postmenopausal women are at an increased risk of developing sarcopenia and osteoporosis as a result of deterioration of musculoskeletal health. Both disorders increase the risk of falls and fractures. The risk of developing sarcopenia and osteoporosis may be attenuated through...

Bibliografske podrobnosti
Main Authors:	Rizzoli, R, Stevenson, J, Bauer, J, van Loon, L, Walrand, S, Kanis, J, Cooper, C, Brandi, M, Diez-Perez, A, Reginster, J
Format:	Journal article
Jezik:	English
Izdano:	2014

Podobne knjige/članki

The role of calcium supplementation in healthy musculoskeletal ageing : An expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Foundation for Osteoporosis (IOF).
od: Harvey, N, et al.
Izdano: (2016)

Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).
od: Cooper, C, et al.
Izdano: (2012)

Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
od: Rizzoli, R, et al.
Izdano: (2013)

Health economics in the field of osteoarthritis: an expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
od: Hiligsmann, M, et al.
Izdano: (2013)

THE EUROPEAN SOCIETY FOR CLINICAL AND ECONOMIC ASPECTS OF OSTEOPOROSIS AND OSTEOARTHRITIS (ESCEO) ALGORITHM FOR THE MANAGEMENT OF KNEE OSTEOARTHRITIS IS APPLICABLE TO RUSSIAN CLINICAL PRACTICE: A CONSENSUS STATEMENT OF LEADING RUSSIAN AND ESCEO OSTEOARTHRITIS EXPERTS
od: L. N. Denisov, et al.
Izdano: (2017-01-01)

Recommendations for the reporting of harms in manuscripts on clinical trials assessing osteoarthritis drugs: A consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
od: Honvo, G, et al.
Izdano: (2019)

Guidelines for the conduct of pharmacological clinical trials in hand osteoarthritis: Consensus of a working group of the european society on clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO)
od: Reginster, J, et al.
Izdano: (2017)

An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
od: Bruyère, O, et al.
Izdano: (2014)

A reference case for economic evaluations in osteoarthritis: An expert consensus article from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
od: Hiligsmann, M, et al.
Izdano: (2014)

European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) Newsletter
od: RENE RIZZOLI, et al.
Izdano: (2007-08-01)

IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases — 2023: the Ukrainian Association of Osteoporosis participation
od: N.V. Kuprinenko
Izdano: (2023-09-01)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
od: Kanis, J, et al.
Izdano: (2013)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
od: Kanis, J, et al.
Izdano: (2008)

Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis.
od: Rizzoli, R, et al.
Izdano: (2011)

Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation.
od: Delmas, P, et al.
Izdano: (2005)

Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG
od: Peyman Hadji, et al.
Izdano: (2017-06-01)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women (Osteoporosis International DOI: 10.1007/s00198-008-0560-z)
od: Kanis, J, et al.
Izdano: (2008)

Guidelines for the conduct of pharmacological clinical trials in hand osteoarthritis: consensus of a working group of the ESCEO
od: Reginster, J, et al.
Izdano: (2018)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women (vol 19, pg 399, 2008)
od: Kanis, J, et al.
Izdano: (2008)

Non-surgical management of knee osteoarthritis: comparison of ESCEO and OARSI 2019 guidelines
od: Arden, NK, et al.
Izdano: (2020)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
od: Rizzoli, R, et al.
Izdano: (2011)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
od: Rizzoli, R, et al.
Izdano: (2011)

Partial adherence: a new perspective on health economic assessment in osteoporosis.
od: Kanis, J, et al.
Izdano: (2011)

A reappraisal of generic bisphosphonates in osteoporosis.
od: Kanis, J, et al.
Izdano: (2012)

Treatment of osteoporosis in men.
od: Kaufman, J, et al.
Izdano: (2013)

DEVELOPMENT AND VALIDATION OF A DISEASE MODEL FOR POSTMENOPAUSAL OSTEOPOROSIS
od: Gauthier, A, et al.
Izdano: (2009)

The International Osteoporosis Foundation: history, objectives and achievements.
od: Cooper, C, et al.
Izdano: (2009)

The International Osteoporosis Foundation: History, objectives and achievements
od: Cooper, C, et al.
Izdano: (2009)

Management of glucocorticoid-induced osteoporosis.
od: Rizzoli, R, et al.
Izdano: (2012)

Development and validation of a disease model for postmenopausal osteoporosis.
od: Gauthier, A, et al.
Izdano: (2011)

Antidepressant medications and osteoporosis
od: Rizzoli, R, et al.
Izdano: (2012)

TASL, TADE, and DAROC consensus for the screening and management of hepatitis C in patients with diabetesConsensus statementsConsensus statementsConsensus statementsConsensus statementsConsensus statementsConsensus statementsConsensus statementsConsensus statementsConsensus statementsConsensus statementsConsensus statements
od: Ming-Lung Yu, et al.
Izdano: (2023-03-01)

Development and validation of a disease model for postmenopausal osteoporosis.
od: Gauthier, A, et al.
Izdano: (2011)

Management of osteoporosis of the oldest old (vol 25, pg 2507, 2014)
od: Rizzoli, R, et al.
Izdano: (2014)

Summary of the Consensus Statements on Osteoporosis Prevention, Diagnosis, and Treatment in the Philippines
od: Julie Li-Yu, et al.
Izdano: (2014-05-01)

Interpretation of expert consensus on prevention and treatment of osteoporosis in perimenopausal and postmenopausal women
od: Xiangyan Ruan, et al.
Izdano: (2022-06-01)

Long treatment with strontium ranelate of womenwith postmenopausal osteoporosis: 10-year results
od: J Y Reginster, et al.
Izdano: (2011-04-01)

Challenges for the development of bone-forming agents in Europe
od: Kanis, J, et al.
Izdano: (2014)

Challenges for the development of bone-forming agents in Europe.
od: Kanis, J, et al.
Izdano: (2014)

Burden of postmenopausal osteoporosis in Germany: estimations from a disease model
od: Gauthier, A, et al.
Izdano: (2012)